Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Humanized antibodies to LIV-1 and use of same to treat cancer

Humanized antibodies to LIV-1 and use of same to treat cancer

US Patent 9783608 · Granted Oct 10, 2017

Estimated economic value: $91,907,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cysteine mutated antibodies for conjugation2024
Glypican 3 antibodies and conjugates thereof2023
BCMA antibodies and use of same to treat cancer and immunological disorders2023
Detection and treatment of CD30+ cancers2022
Anti-NTB-A antibodies and related compositions and methods2022
Combination therapy using a LIV1-ADC and a chemotherapeutic2022
Methods and compositions for making antibodies and antibody derivatives with red2022
Humanized antibodies to LIV-1 and use of same to treat cancer2022
Humanized antibodies to LIV-1 and use of same to treat cancer2022
Humanized antibodies to LIV-1 and use of same to treat cancer2022
Humanized antibodies to LIV-1 and use of same to treat cancer2022
Combinations of PBD-based antibody drug conjugates with FLT3 inhibitors2021